These commonalities suggest a shared mechanism for EVI1 activation in all 3q26-rearranged leukemias, whereby an active hematopoietic enhancer is hijacked by a CTCF-mediated loop with the EVI1 promoter. The gene discussed is MECOM; the disease is leukemia.